Therefore, in addition to its role as an epigenetic modifier that modulates prostate cancer cistromes, EZH2 also acts through additional direct and indirect mechanisms to regulate AR-driven prostate cancer progression (Figure 2). Here, EZH2 is linked to prostate carcinoma.